Name: Clostridium perfringens S107
Creator: BacDive
License: http://creativecommons.org/licenses/by-nc/4.0/

Strain identifier

BacDive ID: 2631

Type strain:

Species: Clostridium perfringens

Strain Designation: S107

Culture col. no.: DSM 756, ATCC 13124, ATCC 19408, NCIB 6125, NCTC 6125, NCTC 8237, WDCM 00007, CCUG 1795, CIP 103409, JCM 1290, BCRC 10913, CCM 4435, CECT 376, KCTC 3269, LMG 11264, NCIMB 6125

Strain history: ATCC 13124 <-- NCTC 8237 ("Clostridium welchii") <-- Wellcome Lab.; CN 1491.

NCBI tax ID(s): 195103 (strain), 1502 (species)

Other strains from Clostridium perfringens

Section

Clostridium perfringens S107 is an anaerobe, mesophilic human pathogen that produces toxins and was isolated from bovine.

toxin production
anaerobe
human pathogen
mesophilic
16S sequence
Bacteria
genome sequence

Information on the name and the taxonomic classification. Name and taxonomic classification

	Last LPSN update	25-08-2022 (DD-MM-YYYY)
	Domain	Bacteria
	Phylum	Bacillota
	Class	Clostridia
	Order	Eubacteriales
	Family	Clostridiaceae
	Genus	Clostridium
	Species	Clostridium perfringens
	Full Scientific Name (PNU)	Clostridium perfringens (Veillon and Zuber 1898) Hauduroy et al. 1937 (Approved Lists 1980)

Synonym

Bacillus perfringens

Information on culture and growth conditions Culture and growth conditions

[Ref.: #428]

Culture medium

COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)

[Ref.: #428]

Culture medium growth

[Ref.: #428]

Culture medium link

Medium recipe at MediaDive

[Ref.: #428]

Culture medium composition

expand / minimize

[Ref.: #428]

Culture medium

FASTIDIOUS ANAEROBE BROTH (DSMZ Medium 1203a)

[Ref.: #428]

Culture medium growth

[Ref.: #428]

Culture medium link

Medium recipe at MediaDive

[Ref.: #428]

Culture medium composition

expand / minimize

[Ref.: #428]

Culture medium

CHOPPED MEAT MEDIUM WITH CARBOHYDRATES (DSMZ Medium 110)

[Ref.: #428]

Culture medium growth

[Ref.: #428]

Culture medium link

Medium recipe at MediaDive

[Ref.: #428]

Culture medium composition

expand / minimize

[Ref.: #42056]

Culture medium

MEDIUM 20 - for Anaerobic bacteria

[Ref.: #42056]

Culture medium growth

[Ref.: #42056]

Culture medium composition

expand / minimize

		Temperature
[Ref.: #428]	growth	37 °C
[Ref.: #42056]	growth	37 °C
[Ref.: #44424]	growth	37 °C
[Ref.: #67770]	growth	37 °C

[Ref.: #428]	Temperature range	mesophilic
[Ref.: #42056]	Temperature range	mesophilic
[Ref.: #44424]	Temperature range	mesophilic
[Ref.: #67770]	Temperature range	mesophilic

Information on physiology and metabolism Physiology and metabolism

[Ref.: #428]	Oxygen tolerance	anaerobe
[Ref.: #44424]	Oxygen tolerance	anaerobe

[Ref.: #428]	Name of produced compound	haemolysins
[Ref.: #428]	Name of produced compound	lecithinase
[Ref.: #428]	Name of produced compound	lethal toxins
[Ref.: #428]	Name of produced compound	phospholipase C
[Ref.: #67770]	Name of produced compound	haemolysins
[Ref.: #67770]	Name of produced compound	lethal toxins

	Metabolite	Utilization activity	Kind of utilization tested
[Ref.: #68380]	arginine ChEBI	+	hydrolysis	* from API rID32A
[Ref.: #68367]	cellobiose ChEBI	-	builds acid from	* from API 20A
[Ref.: #68367]	D-glucose ChEBI	+	builds acid from	* from API 20A
[Ref.: #68367]	D-mannose ChEBI	+	builds acid from	* from API 20A
[Ref.: #68380]	D-mannose ChEBI	+	fermentation	* from API rID32A
[Ref.: #68367]	D-xylose ChEBI	-	builds acid from	* from API 20A
[Ref.: #68367]	esculin ChEBI	+	hydrolysis	* from API 20A
[Ref.: #68367]	gelatin ChEBI	+	hydrolysis	* from API 20A
[Ref.: #68367]	L-arabinose ChEBI	-	builds acid from	* from API 20A
[Ref.: #68380]	L-glutamate ChEBI	-	degradation	* from API rID32A
[Ref.: #68367]	L-rhamnose ChEBI	-	builds acid from	* from API 20A
[Ref.: #68367]	lactose ChEBI	+	builds acid from	* from API 20A
[Ref.: #68367]	maltose ChEBI	+	builds acid from	* from API 20A
[Ref.: #68367]	melezitose ChEBI	-	builds acid from	* from API 20A
[Ref.: #68380]	nitrate ChEBI	+	reduction	* from API rID32A
[Ref.: #68380]	raffinose ChEBI	+	fermentation	* from API rID32A
[Ref.: #68367]	raffinose ChEBI	-	builds acid from	* from API 20A
[Ref.: #68367]	salicin ChEBI	-	builds acid from	* from API 20A
[Ref.: #68367]	sorbitol ChEBI	-	builds acid from	* from API 20A
[Ref.: #68367]	sucrose ChEBI	+	builds acid from	* from API 20A
[Ref.: #68367]	trehalose ChEBI	+	builds acid from	* from API 20A
[Ref.: #68380]	tryptophan ChEBI	-	energy source	* from API rID32A, API 20A
[Ref.: #68380]	urea ChEBI	-	hydrolysis	* from API rID32A, API 20A
	Only first 10 entries are displayed. Click here to see all.

	Metabolite production	Metabolite
[Ref.: #68380]		indole ChEBI	* from API rID32A, API 20A

	Physiological tests	Metabolite	Indole test
[Ref.: #68380]		indole ChEBI	-	* from API rID32A, API 20A

	Enzyme	Enzyme activity	EC number
[Ref.: #68380]	alanine arylamidase	-	3.4.11.2	* from API rID32A
[Ref.: #68380]	alkaline phosphatase	+	3.1.3.1	* from API rID32A
[Ref.: #68380]	alpha-arabinosidase	-	3.2.1.55	* from API rID32A
[Ref.: #68380]	alpha-fucosidase	+	3.2.1.51	* from API rID32A
[Ref.: #68380]	alpha-galactosidase	+	3.2.1.22	* from API rID32A
[Ref.: #68380]	alpha-glucosidase	+	3.2.1.20	* from API rID32A
[Ref.: #68380]	arginine dihydrolase	+	3.5.3.6	* from API rID32A
[Ref.: #68380]	beta-galactosidase	+	3.2.1.23	* from API rID32A
[Ref.: #68367]	beta-glucosidase	+	3.2.1.21	* from API 20A
[Ref.: #68380]	beta-glucuronidase	-	3.2.1.31	* from API rID32A
[Ref.: #68367]	gelatinase	+		* from API 20A
[Ref.: #68380]	glutamate decarboxylase	-	4.1.1.15	* from API rID32A
[Ref.: #68380]	glutamyl-glutamate arylamidase	-		* from API rID32A
[Ref.: #68380]	glycin arylamidase	-		* from API rID32A
[Ref.: #68380]	histidine arylamidase	-		* from API rID32A
[Ref.: #68380]	L-arginine arylamidase	-		* from API rID32A
[Ref.: #68380]	leucine arylamidase	-	3.4.11.1	* from API rID32A
[Ref.: #68380]	leucyl glycin arylamidase	-	3.4.11.1	* from API rID32A
[Ref.: #68380]	N-acetyl-beta-glucosaminidase	+	3.2.1.52	* from API rID32A
[Ref.: #68380]	phenylalanine arylamidase	-		* from API rID32A
[Ref.: #67770]	phospholipase C		3.1.4.11
[Ref.: #68380]	proline-arylamidase	-	3.4.11.5	* from API rID32A
[Ref.: #68380]	pyrrolidonyl arylamidase	+	3.4.19.3	* from API rID32A
[Ref.: #68380]	serine arylamidase	-		* from API rID32A
[Ref.: #68380]	tryptophan deaminase	-	4.1.99.1	* from API rID32A
[Ref.: #68380]	tyrosine arylamidase	-		* from API rID32A
[Ref.: #68380]	urease	-	3.5.1.5	* from API rID32A, API 20A
	Only first 10 entries are displayed. Click here to see all.

API® 20A:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Indole productionIND	Urease/urea hydrolysisURE	Acid from D-glucoseGLU	Acid from D-mannitolMAN	Acid from lactoseLAC	Acid from sucroseSAC	Acid from maltoseMAL	Acid from salicinSAL	Acid from D-xyloseXYL	Acid from L-arabinoseARA	Gelatinase/gelatin hydrolysisGEL	Esculin hydrolysis/beta-glucosidaseESC	Acid from glycerolGLY	Acid from cellobioseCEL	Acid from D-mannoseMNE	Acid from melezitoseMLZ	Acid from raffinoseRAF	Acid from sorbitolSOR	Acid from L-rhamnoseRHA	Acid from trehaloseTRE	CatalaseCAT	Spores presentSPOR	GramGRAM	Morphology coccus="+" rod="-"COCC
[Ref.: #428]	1471	-	-	+	-	+	+	+	-	-	-	+	+	-	-	+	-	-	-	-	+	not determinedn.d.	not determinedn.d.	not determinedn.d.	not determinedn.d.
[Ref.: #428]	1448	-	-	+	+/-	+	+	+	-	-	-	+	+	+	-	+	-	-	-	-	+	not determinedn.d.	not determinedn.d.	not determinedn.d.	not determinedn.d.

API® rID32A:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Urease/urea hydrolysisURE	Arginine dihydrolaseADH (Arg)	alpha-Galactosidasealpha GAL	beta-Galactosidasebeta GAL	beta-Galactosidase 6-phosphatebeta GP	alpha-Glucosidasealpha GLU	beta-Glucosidasebeta GLU	alpha-Arabinosidasealpha ARA	beta-Glucuronidasebeta GUR	beta-N-Acetyl-beta-glucosaminidasebeta NAG	Fermentation of D-mannoseMNE	Fermentation of raffinoseRAF	Glutamate decarboxylaseGDC	alpha-Fucosidasealpha FUC	Reduction of nitrateNIT	Indole productionIND	Alkaline phosphatasePAL	L-arginine arylamidaseArgA	Proline arylamidaseProA	Leucyl glycin arylamidaseLGA	Phenylalanine arylamidasePheA	Leucine arylamidaseLeuA	Pyrrolidonyl arylamidasePyrA	Tyrosine arylamidaseTyrA	Alanine arylamidaseAlaA	Glycin arylamidaseGlyA	Histidine arylamidaseHisA	Glutamyl-glutamate arylamidaseGGA	Serine arylamidaseSerA
[Ref.: #428]	9328	-	+	+	+	-	+	-	-	-	+	+	+	-	+	+	-	+	-	-	-	-	-	+	-	-	-	-	-	-
[Ref.: #428]	9236	-	+	+	+	+	+	+	-	-	+	+	+	-	+	+	-	+	-	-	-	-	-	+	-	-	-	-	-	-

Information on isolation source, the sampling and environmental conditions Isolation, sampling and environmental information

[Ref.: #428]	Sample type/isolated from	bovine

[Ref.: #44424]	Sample type/isolated from	Bovine

[Ref.: #67770]	Sample type/isolated from	Bovine

Isolation sources categories

#Host

#Mammals

#Bovinae (Cow, Cattle)

What are isolation sources categories?

Information on possible application of the strain and its possible interaction with e.g. potential hosts Safety information

[Ref.: #428]	Pathogenicity (human)	yes
[Ref.: #428]	Pathogenicity (animal)	yes
[Ref.: #428]	Biosafety level	2	Risk group (German classification) According to TRBA 466

Information on genomic background e.g. entries in nucleic sequence databass Sequence information

16S Sequence information:

Only first 5 entries are displayed. Click here to see all.

	Sequence accession description	Seq. accession number	Sequence length (bp)	Sequence database	Associated NCBI tax ID
[Ref.: #20218]	Clostridium perfringens gene for 16S rRNA, partial sequence, strain: ATCC 13124	AB075767	1460	ENA	195103 tax ID	*
[Ref.: #20218]	Clostridium perfringens partial 16S rRNA gene, strain ATCC 13124	FM207095	390	ENA	195103 tax ID	*
[Ref.: #20218]	Clostridium perfringens strain DSM 756 16S ribosomal RNA gene, partial sequence	HQ012013	933	ENA	1502 tax ID	*
[Ref.: #20218]	Clostridium perfringens 16S ribosomal RNA	M59103	1462	ENA	1502 tax ID	*
[Ref.: #20218]	{16S/23S ribosomal DNA spacer region} [Clostridium perfringens, ATCC 13124, Genomic, 239 nt]	S51964	239	ENA	1502 tax ID	*
[Ref.: #67770]	Clostridium perfringens gene for 16S ribosomal RNA, partial sequence, strain: JCM 1290	AB573713	1474	ENA	1502 tax ID

Genome sequence information:

	Sequence accession description	Seq. accession number	Assembly level (bp)	Sequence database	Associated NCBI tax ID
[Ref.: #66792]	Clostridium perfringens ATCC 13124 ATCC 13124	GCA_000013285	complete	GenBank	195103 tax ID	*
[Ref.: #66792]	Clostridium perfringens ATCC 13124	195103.10	complete	PATRIC	195103 tax ID	*
[Ref.: #66792]	Clostridium perfringens strain FDAARGOS_903 strain Not applicable	1502.1789	complete	PATRIC	1502 tax ID	*
[Ref.: #66792]	Clostridium perfringens ATCC 13124	637000077	complete	JGI IMG/M	195103 tax ID	*
[Ref.: #67770]	Clostridium perfringens ATCC 13124, complete genome	CP000246		ENA	195103 tax ID

[Ref.: #428]	GC-content	24.0 mol%
[Ref.: #67770]	GC-content	24 mol%	thermal denaturation, midpoint method (Tm)

Availability in culture collections External links

[Ref.: #428]

Culture collection no.

DSM 756, ATCC 13124, ATCC 19408, NCIB 6125, NCTC 6125, NCTC 8237, WDCM 00007, CCUG 1795, CIP 103409, JCM 1290, BCRC 10913, CCM 4435, CECT 376, KCTC 3269, LMG 11264, NCIMB 6125

[Ref.: #20218]

Associated Passport(s) in StrainInfo

7948, 7940, 7941, 7951, 7952, 7953, 866259

Literature:

Only first 10 entries are displayed. Click here to see all.

Title	Authors	Journal	DOI	Year	Mesh	Topic	Topic2
Production of phospholipase C (alpha-toxin), haemolysins and lethal toxins by Clostridium perfringens types A to D.	Mollby R, Holme T, Nord CE, Smyth CJ, Wadstrom T	J Gen Microbiol	10.1099/00221287-96-1-137	1976	Abdominal Injuries/microbiology, Clostridium Infections/microbiology, Clostridium perfringens/classification/growth & development/metabolism, Feces/microbiology, Gas Gangrene/microbiology, Hemolysin Proteins/biosynthesis, Humans, Hydrogen-Ion Concentration, Phospholipases/biosynthesis, Serotyping, Species Specificity, Toxins, Biological/biosynthesis	Pathogenicity	Phylogeny	*
Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria.	Sutter VL, Barry AL, Wilkins TD, Zabransky RJ	Antimicrob Agents Chemother	10.1128/AAC.16.4.495	1979	Anaerobiosis, Anti-Bacterial Agents/pharmacology, Bacteria/drug effects, Culture Media, Evaluation Studies as Topic, Microbial Sensitivity Tests/*methods	Cultivation	Pathogenicity	*
Collagenase of Clostridium perfringens type A: degradation of human complement component C1q.	Wolf U, Bauer D, Traub WH	Zentralbl Bakteriol	10.1016/s0934-8840(11)80215-x	1991	Blotting, Western, Clostridium perfringens/enzymology, Complement C1q/metabolism, Electrophoresis, Polyacrylamide Gel, Humans, Isoelectric Point, Microbial Collagenase/chemistry/isolation & purification/*metabolism, Molecular Weight	Enzymology	Metabolism	*
Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem.	Zabransky RJ, Bayola-Mueller L, Jenkins SG, Pitkin DR, Schreckenberger PC, Celig DM, Spiegel CA	J Clin Microbiol	10.1128/jcm.28.12.2804-2805.1990	1990	Bacteria, Anaerobic/drug effects, Meropenem, Microbial Sensitivity Tests/methods/standards, Quality Control, Reference Values, Thienamycins/*pharmacology	Pathogenicity		*
Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria.	Zabransky RJ, Bobey DG, Barry AL, Allen SD, Fuchs PC, Gerlach EH, Thornsberry C, Sheikh W, Jones RN	J Clin Microbiol	10.1128/jcm.27.1.190-191.1989	1989	Bacteria, Anaerobic/drug effects, Cefotetan/pharmacology, Microbial Sensitivity Tests/*standards, Multicenter Studies as Topic, Quality Control, Reference Values	Pathogenicity		*
Effect of antibiotics on toxin production and viability of Clostridium perfringens.	Stevens DL, Maier KA, Mitten JE	Antimicrob Agents Chemother	10.1128/AAC.31.2.213	1987	Anti-Bacterial Agents/pharmacology, Bacterial Toxins/biosynthesis, Calcium-Binding Proteins, Cefoxitin/pharmacology, Chloramphenicol/pharmacology, Clindamycin/pharmacology, Clostridium perfringens/drug effects/growth & development/metabolism, Kinetics, Metronidazole/pharmacology, Microbial Sensitivity Tests, Penicillin G/pharmacology, Rifampin/pharmacology, Tetracycline/pharmacology, *Type C Phospholipases	Pathogenicity	Enzymology	*
Evaluation of some commercial media for the cultivation and enumeration of Clostridium perfringens from the chick intestine.	Dafwang II, Ricke SC, Schaefer DM, Brotz PG, Sunde ML, Pringle DJ	Poult Sci	10.3382/ps.0660652	1987	Animals, Chickens/microbiology, Clostridium perfringens/growth & development/isolation & purification, Culture Media, Intestines/*microbiology	Cultivation	Enzymology	*
Growth curves of Clostridium perfringens in Schaedler and brain heart infusion broths.	Traub WH, Spohr M, Bauer D	Zentralbl Bakteriol Mikrobiol Hyg A	10.1016/s0176-6724(87)80035-4	1987	Animals, Clostridium perfringens/*growth & development/pathogenicity, Culture Media, Humans, Mice, Virulence	Cultivation	Pathogenicity	*
Cloning and expression in Escherichia coli of the perfringolysin O (theta-toxin) gene from Clostridium perfringens and characterization of the gene product.	Tweten RK	Infect Immun	10.1128/iai.56.12.3228-3234.1988	1988	Amino Acid Sequence, Bacterial Toxins/genetics/metabolism, Cloning, Molecular, Clostridium perfringens/genetics, Escherichia coli/genetics/metabolism, Genes, Bacterial, Hemolysin Proteins, Hemolysis, Molecular Sequence Data, Molecular Weight, Peptide Mapping, Recombinant Proteins/genetics, Restriction Mapping	Enzymology	Metabolism	*
Inactivation of cefoxitin and moxalactam by Bacteroides bivius beta-lactamase.	Malouin F, Fijalkowski C, Lamothe F, Lacroix JM	Antimicrob Agents Chemother	10.1128/AAC.30.5.749	1986	Bacteroides/enzymology, Biological Assay, Cefoxitin/antagonists & inhibitors/pharmacology, Hydrolysis, Microbial Sensitivity Tests, Moxalactam/antagonists & inhibitors/pharmacology, Spectrophotometry, Ultraviolet, beta-Lactamases/pharmacology	Enzymology		*
Establishment of MICs of moxalactam for control and reference anaerobic organisms in agar dilution and microdilution techniques.	Sutter VL, Emmerman J, Randall E, Zabransky RJ, Birk RJ	Antimicrob Agents Chemother	10.1128/AAC.27.3.424	1985	Agar, Bacteria, Anaerobic/drug effects, Microbial Sensitivity Tests, Microbiological Techniques, Moxalactam/pharmacology	Pathogenicity		*
Evaluation of broth microdilution susceptibility results for anaerobic organisms by use of a rapid direct colony inoculum.	Mangels JI, Lindberg LH	J Clin Microbiol	10.1128/jcm.21.2.269-272.1985	1985	Bacteria, Anaerobic/drug effects, Humans, Microbial Sensitivity Tests/methods, Quality Control, Tetracycline/pharmacology	Pathogenicity		*
Establishment of minimum inhibitory concentrations of cefoperazone for control and reference anaerobic organisms.	Zabransky RJ, Randall E, Sutter VL, Birk RJ, Westenfelder G, Emmerman J, Ghoneim AT	J Clin Microbiol	10.1128/jcm.17.4.711-714.1983	1983	Anaerobiosis, Bacteria/drug effects, Cefoperazone, Cephalosporins/pharmacology, Microbial Sensitivity Tests	Pathogenicity		*
Synthesis and evaluation of a non-radioactive gene probe for the detection of C.perfringens alpha toxin.	Schlapp T, Blaha I, Bauerfeind R, Wieler LH, Schoepe H, Weiss R, Baljer G	Mol Cell Probes	10.1016/s0890-8508(95)80034-4	1995	Bacillus cereus/classification, Bacterial Toxins/analysis/genetics, Base Sequence, Calcium-Binding Proteins, Chromosomes, Bacterial, Clostridium/classification/genetics, Clostridium perfringens/classification/genetics/isolation & purification, DNA Primers/chemical synthesis, Genes, Bacterial, Humans, Listeria monocytogenes/classification, Molecular Sequence Data, Nucleic Acid Hybridization, Staphylococcus aureus/classification, *Type C Phospholipases	Phylogeny	Pathogenicity	*
Role of alpha-toxin in Clostridium perfringens infection determined by using recombinants of C. perfringens and Bacillus subtilis.	Ninomiya M, Matsushita O, Minami J, Sakamoto H, Nakano M, Okabe A	Infect Immun	10.1128/iai.62.11.5032-5039.1994	1994	Animals, Bacillus subtilis, Bacterial Toxins/metabolism/toxicity, Calcium-Binding Proteins, Clostridium Infections/pathology/physiopathology, Clostridium perfringens/pathogenicity, Erythrocyte Count, Gas Gangrene/physiopathology, Hemolysin Proteins, Macrophages, Peritoneal/microbiology, Male, Mice, Platelet Count, Transformation, Genetic, Type C Phospholipases/metabolism	Metabolism	Pathogenicity	*
16S ribosomal DNA sequences of anaerobic cocci and proposal of Ruminococcus hansenii comb. nov. and Ruminococcus productus comb. nov.	Ezaki T, Li N, Hashimoto Y, Miura H, Yamamoto H	Int J Syst Bacteriol	10.1099/00207713-44-1-130	1994	Anaerobiosis, Base Sequence, DNA, Bacterial/chemistry, DNA, Ribosomal/chemistry, Molecular Sequence Data, Peptococcaceae/classification/genetics, RNA, Ribosomal, 16S/*genetics	Phylogeny	Genetics	*
Comparison of the alpha-toxin genes of Clostridium perfringens type A and C strains: evidence for extragenic regulation of transcription.	Katayama S, Matsushita O, Minami J, Mizobuchi S, Okabe A	Infect Immun	10.1128/iai.61.2.457-463.1993	1993	Amino Acid Sequence, Bacterial Toxins/genetics, Base Sequence, Calcium-Binding Proteins, Clostridium perfringens/enzymology/genetics/pathogenicity, Escherichia coli/genetics, Gene Expression Regulation, Genes, Bacterial, Molecular Sequence Data, RNA, Messenger/analysis, Transcription, Genetic, Type C Phospholipases/genetics	Genetics	Pathogenicity	*
Diversity in the properties of two sialidase isoenzymes produced by Clostridium perfringens spp.	Roggentin P, Kleineidam RG, Schauer R	Biol Chem Hoppe Seyler	10.1515/bchm3.1995.376.9.569	1995	Chromatography, Gel, Clostridium perfringens/enzymology, Electrophoresis, Polyacrylamide Gel, Hydrogen-Ion Concentration, Hydrolysis, Isoelectric Focusing, Isoenzymes/chemistry/metabolism, Kinetics, Molecular Weight, Neuraminidase/chemistry/*metabolism, Recombinant Proteins/biosynthesis, Substrate Specificity, Temperature	Enzymology	Metabolism	*
Molecular variation between the alpha-toxins from the type strain (NCTC 8237) and clinical isolates of Clostridium perfringens associated with disease in man and animals.	Ginter A, Williamson ED, Dessy F, Coppe P, Bullifent H, Howells A, Titball RW	Microbiology (Reading)	10.1099/13500872-142-1-191	1996	Animals, Antibodies, Bacterial, Antibodies, Monoclonal, Antibody Specificity, Bacterial Toxins/genetics/immunology/therapeutic use/toxicity, Bacterial Vaccines/therapeutic use, Base Sequence, Calcium-Binding Proteins, Cattle, Clostridium Infections/prevention & control, Clostridium perfringens/genetics/pathogenicity, Epitope Mapping, Female, Genetic Variation, Humans, Intestinal Diseases/microbiology, Mice, Mice, Inbred BALB C, Molecular Sequence Data, Peptide Fragments/immunology, Sequence Analysis, DNA, Soft Tissue Infections/microbiology, Species Specificity, Type C Phospholipases/analysis, Vaccines, Synthetic/*therapeutic use, Virulence	Pathogenicity	Genetics	*
Characterization of a toxin-deficient Clostridium perfringens strain, KZ1340.	Shimizu T, Ohtani K, Ba-Thein W, Inui S, Nakamura S, Hayashi H	Microbiol Immunol	10.1111/j.1348-0421.1996.tb03329.x	1996	Bacterial Toxins/genetics/metabolism, Calcium-Binding Proteins, Clostridium perfringens/genetics/isolation & purification/metabolism, Genes, Bacterial, Hemolysin Proteins, Microbial Collagenase/genetics/metabolism, Plasmids, Transcription, Genetic, Transformation, Genetic, Type C Phospholipases	Metabolism	Pathogenicity	*
Improved isolation of Clostridium perfringens from foal faeces.	Netherwood T, Chanter N, Mumford JA	Res Vet Sci	10.1016/s0034-5288(96)90090-9	1996	Animals, Bacteriological Techniques, Clostridium Infections/diagnosis/veterinary, Clostridium perfringens/isolation & purification/physiology, Diarrhea/microbiology/veterinary, Feces/microbiology, Horse Diseases, Horses, Spores, Bacterial	Phylogeny	Enzymology	*
Collagenase gene (colA) is located in the 3'-flanking region of the perfringolysin O (pfoA) locus in Clostridium perfringens.	Ohtani K, Bando M, Swe T, Banu S, Oe M, Hayashi H, Shimizu T	FEMS Microbiol Lett	10.1111/j.1574-6968.1997.tb10186.x	1997	Amino Acid Sequence, Bacterial Toxins/genetics, Base Sequence, Chromosome Mapping, Clostridium perfringens/enzymology/genetics/pathogenicity, Collagenases/genetics, DNA Primers/genetics, *Genes, Bacterial, Hemolysin Proteins, Molecular Sequence Data, Open Reading Frames, Virulence/genetics, beta-Galactosidase/genetics	Genetics	Pathogenicity	*
Evaluation of the synergistic haemolysis (CAMP-like) test in the identification of motile, mesophilic Aeromonas species.	Gubash SM	Zentralbl Bakteriol	10.1016/s0934-8840(97)80073-4	1997	Aeromonas/classification/isolation & purification, Aeromonas hydrophila/isolation & purification, Animals, Bacterial Toxins/immunology, Bacterial Typing Techniques, Clostridium perfringens/immunology, Erythrocytes/immunology, Hemolysin Proteins, Hemolysis, Sheep, *Sphingomyelin Phosphodiesterase, Staphylococcus aureus/immunology	Phylogeny	Enzymology	*
Crystallization and preliminary X-ray diffraction studies of alpha-toxin from two different strains (NCTC8237 and CER89L43) of Clostridium perfringens.	Basak AK, Howells A, Eaton JT, Moss DS, Naylor CE, Miller J, Titball RW	Acta Crystallogr D Biol Crystallogr	10.1107/s0907444998005186	1998	Bacterial Toxins/chemistry/isolation & purification, Calcium-Binding Proteins, Clostridium perfringens/chemistry/classification, Crystallization, Crystallography, X-Ray, Escherichia coli, Protein Conformation, Recombinant Fusion Proteins/chemistry/isolation & purification, Species Specificity, Type C Phospholipases/chemistry/isolation & purification	Phylogeny	Enzymology	*
A Clostridium perfringens hem gene cluster contains a cysG(B) homologue that is involved in cobalamin biosynthesis.	Koyama M, Katayama S, Kaji M, Taniguchi Y, Matsushita O, Minami J, Morita S, Okabe A	Microbiol Immunol	10.1111/j.1348-0421.1999.tb03355.x	1999	Base Sequence, Cloning, Molecular, Clostridium perfringens/genetics/growth & development, DNA, Bacterial, Genes, Bacterial, Methyltransferases/genetics, Molecular Sequence Data, Multigene Family, Mutagenesis, Open Reading Frames, Sequence Analysis, DNA, Sequence Homology, Amino Acid, Vitamin B 12/*biosynthesis	Enzymology	Genetics	*
An effective lacticin biopreservative in fresh pork sausage.	Scannell AG, Ross RP, Hill C, Arendt EK	J Food Prot	10.4315/0362-028x-63.3.370	2000	Animals, Bacterial Proteins/pharmacology, Bacteriocins/pharmacology, Clostridium perfringens/growth & development, Culture Media, Food Handling, Food Preservation, Food Preservatives/pharmacology, Lactococcus lactis/metabolism, Listeria/growth & development, Meat Products/microbiology, Salmonella/growth & development, Swine	Cultivation	Metabolism	*
Bactericidal properties of the chloroform fraction from rhizomes of Aristolochia paucinervis Pomel.	Gadhi CA, Hatier R, Mory F, Marchal L, Weber M, Benharref A, Jana M, Lozniewski A	J Ethnopharmacol	10.1016/s0378-8741(01)00185-4	2001	Anti-Bacterial Agents/pharmacology, Chloroform/chemistry, Clostridium perfringens/drug effects/ultrastructure, Enterococcus faecalis/drug effects/ultrastructure, Magnoliopsida/chemistry, Microbial Sensitivity Tests, Microscopy, Electron, Plant Extracts/*pharmacology	Pathogenicity		*
In vitro effect of intracanal medicaments on strict anaerobes by means of the broth dilution method.	Rosa OP, Torres SA, Ferreira CM, Ferreira FB	Pesqui Odontol Bras	10.1590/s1517-74912002000100006	2002	Bacteria, Anaerobic/drug effects, Indicator Dilution Techniques, Reproducibility of Results, Root Canal Therapy/methods, Therapeutic Irrigation	Pathogenicity		*
Activity of endodontic antibacterial agents against selected anaerobic bacteria.	Ferreira CM, da Silva Rosa OP, Torres SA, Ferreira FB, Bernardinelli N	Braz Dent J	10.1590/s0103-64402002000200008	2002	Bacteria, Anaerobic/drug effects, Bacteroides fragilis/drug effects, Calcium Hydroxide/pharmacology, Camphor/pharmacology, Castor Oil/pharmacology, Chlorhexidine/analogs & derivatives/pharmacology, Chlorophenols/pharmacology, Clostridium perfringens/drug effects, Culture Media, Detergents/pharmacology, Disinfectants/pharmacology, Drug Combinations, Fusobacterium nucleatum/drug effects, Humans, Microbial Sensitivity Tests, Prevotella/drug effects, Root Canal Irrigants/pharmacology, Spectrophotometry	Pathogenicity	Cultivation	*
Growth inhibition of intestinal bacteria and mutagenicity of 2-, 3-, 4-aminobiphenyls, benzidine, and biphenyl.	Chung KT, Adris P	Toxicol In Vitro	10.1016/s0887-2333(02)00131-5	2003	Aminobiphenyl Compounds/toxicity, Benzidines/toxicity, Biphenyl Compounds/toxicity, Gram-Negative Bacteria/drug effects/growth & development, Gram-Positive Bacteria/drug effects/growth & development, Humans, Intestines/microbiology, Mutagenicity Tests, Mutagens/*toxicity	Pathogenicity		*
Susceptibility of Clostridium perfringens to C-C fatty acids.	Skrivanova E, Marounek M, Dlouha G, Kanka J	Lett Appl Microbiol	10.1111/j.1472-765X.2005.01709.x	2005	Clostridium Infections/prevention & control/veterinary, Clostridium perfringens/drug effects/growth & development/ultrastructure, Culture Media, Fatty Acids/administration & dosage/pharmacology, Food Additives/administration & dosage, Glucose, Hydrogen-Ion Concentration, Lauric Acids/pharmacology, Microbial Sensitivity Tests, Microscopy, Electron, Transmission	Cultivation	Pathogenicity	*
Inhibition of Clostridium perfringens by a novel strain of Bacillus subtilis isolated from the gastrointestinal tracts of healthy chickens.	Teo AY, Tan HM	Appl Environ Microbiol	10.1128/AEM.71.8.4185-4190.2005	2005	Animals, Antibiosis, Bacillus subtilis/classification/growth & development/metabolism, Bacteriocins/chemistry/metabolism/pharmacology, Chickens/microbiology, Clostridium perfringens/drug effects/growth & development, Culture Media, Gastrointestinal Tract/microbiology, Hydrogen-Ion Concentration, Microbial Sensitivity Tests/methods, Temperature	Metabolism	Cultivation	*
Cloning, recombinant production, crystallization and preliminary X-ray diffraction studies of a family 84 glycoside hydrolase from Clostridium perfringens.	Ficko-Blean E, Boraston AB	Acta Crystallogr Sect F Struct Biol Cryst Commun	10.1107/S1744309105024012	2005	Catalysis, Cloning, Molecular, Clostridium perfringens/enzymology/genetics, Crystallization, Glycoside Hydrolases/chemistry/genetics, Recombinant Proteins/chemistry, X-Ray Diffraction	Enzymology	Biotechnology	*
Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens.	Myers GS, Rasko DA, Cheung JK, Ravel J, Seshadri R, DeBoy RT, Ren Q, Varga J, Awad MM, Brinkac LM, Daugherty SC, Haft DH, Dodson RJ, Madupu R, Nelson WC, Rosovitz MJ, Sullivan SA, Khouri H, Dimitrov GI, Watkins KL, Mulligan S, Benton J, Radune D, Fisher DJ, Atkins HS, Hiscox T, Jost BH, Billington SJ, Songer JG, McClane BA, Titball RW, Rood JI, Melville SB, Paulsen IT	Genome Res	10.1101/gr.5238106	2006	Bacterial Toxins, Base Sequence, Clostridium perfringens/genetics, DNA, Bacterial, Genome, Bacterial, Molecular Sequence Data, Polymerase Chain Reaction	Genetics	Pathogenicity	*
Detection of fibronectin-binding proteins in Clostridium perfringens.	Katayama S, Nozu N, Yokoyama M, Hitsumoto Y	Acta Med Okayama	10.18926/AMO/30720	2006	Carrier Proteins/metabolism, Clostridium perfringens/metabolism, Fibronectins/*metabolism, Humans, Protein Binding	Metabolism	Pathogenicity	*
Carbon catabolite repression of type IV pilus-dependent gliding motility in the anaerobic pathogen Clostridium perfringens.	Mendez M, Huang IH, Ohtani K, Grau R, Shimizu T, Sarker MR	J Bacteriol	10.1128/JB.01407-07	2007	Anaerobiosis, Animals, Bacterial Proteins/genetics, Chemotaxis/genetics/physiology, Cloning, Molecular, Clostridium perfringens/drug effects/genetics/pathogenicity/physiology, DNA Primers, DNA-Binding Proteins/genetics, Fimbriae, Bacterial/*physiology, Gene Deletion, Genetic Complementation Test, Glucose/pharmacology, Glucuronidase/genetics/metabolism, Humans, Plasmids, Repressor Proteins/genetics	Pathogenicity	Enzymology	*
Identification of galacto-N-biose phosphorylase from Clostridium perfringens ATCC13124.	Nakajima M, Nihira T, Nishimoto M, Kitaoka M	Appl Microbiol Biotechnol	10.1007/s00253-007-1319-8	2008	Bacterial Proteins/genetics/metabolism, Base Sequence, Bifidobacterium/enzymology, Cloning, Molecular, Clostridium perfringens/enzymology/metabolism, Codon, Initiator/analysis, Enzyme Stability, Galactose/metabolism, Humans, Kinetics, Phosphorylases/chemistry/genetics/isolation & purification/metabolism, Phosphorylation, Recombinant Proteins/genetics/metabolism, Substrate Specificity	Enzymology	Metabolism	*
Immunization against Clostridium perfringens cells elicits protection against Clostridium tetani in mouse model: identification of cross-reactive proteins using proteomic methodologies.	Alam SI, Bansod S, Singh L	BMC Microbiol	10.1186/1471-2180-8-194	2008	Animals, Antibodies, Bacterial/immunology, Bacterial Proteins/immunology, Bacterial Vaccines/immunology, Clostridium perfringens/immunology, Clostridium tetani/immunology, Cross Reactions, Female, Immunization, Mice, Mice, Inbred BALB C, Proteome/immunology, Proteomics, Tetanus/immunology	Proteome		*
Characterization of two putative fibronectin-binding proteins of Clostridium perfringens.	Katayama S, Nozu N, Okuda M, Hirota S, Yamasaki T, Hitsumoto Y	Anaerobe	10.1016/j.anaerobe.2009.03.001	2009	Bacterial Proteins/genetics/metabolism, Cloning, Molecular, Clostridium perfringens/genetics/growth & development/isolation & purification/metabolism, Enzyme-Linked Immunosorbent Assay, Fibronectins/*metabolism, Gas Gangrene/microbiology, Gene Expression Regulation, Bacterial, Humans, Polymerase Chain Reaction, Protein Binding, Recombinant Proteins/genetics/metabolism	Metabolism	Enzymology	*
Differential proteomic analysis of Clostridium perfringens ATCC13124; identification of dominant, surface and structure associated proteins.	Alam SI, Bansod S, Kumar RB, Sengupta N, Singh L	BMC Microbiol	10.1186/1471-2180-9-162	2009	Animals, Bacterial Outer Membrane Proteins/metabolism, Clostridium perfringens/metabolism, Computational Biology, Culture Media, Female, Lyases/metabolism, Mass Spectrometry, Mice, Mice, Inbred BALB C, Ornithine Carbamoyltransferase/metabolism, Proteome/*metabolism, Proteomics	Metabolism	Cultivation	*
Virulence for chickens of Clostridium perfringens isolated from poultry and other sources.	Cooper KK, Theoret JR, Stewart BA, Trinh HT, Glock RD, Songer JG	Anaerobe	10.1016/j.anaerobe.2010.02.006	2010	Animals, Bacterial Toxins/metabolism, Calcium-Binding Proteins/metabolism, Cattle, Chickens, Clostridium Infections/microbiology/veterinary, Clostridium perfringens/isolation & purification/pathogenicity, Enteritis/microbiology/veterinary, Humans, Poultry, Poultry Diseases/microbiology, Species Specificity, Swine, Type C Phospholipases/*metabolism, Virulence	Pathogenicity	Metabolism	*
Comparative proteomic analysis of extracellular proteins of Clostridium perfringens type A and type C strains.	Sengupta N, Alam SI, Kumar B, Kumar RB, Gautam V, Kumar S, Singh L	Infect Immun	10.1128/IAI.00374-10	2010	Animals, Bacterial Proteins/analysis/immunology, Clostridium perfringens/chemistry/classification/pathogenicity, Electrophoresis, Gel, Two-Dimensional, Female, Mice, Mice, Inbred BALB C, Ornithine Carbamoyltransferase/immunology, Proteomics/*methods, Virulence	Enzymology	Phylogeny	*
Comparison of a nontoxic variant of Clostridium perfringens alpha-toxin with the toxic wild-type strain.	Vachieri SG, Clark GC, Alape-Giron A, Flores-Diaz M, Justin N, Naylor CE, Titball RW, Basak AK	Acta Crystallogr D Biol Crystallogr	10.1107/S090744491003369X	2010	Animals, Apoptosis/drug effects/genetics, Bacterial Toxins/chemistry/genetics/metabolism/toxicity, Calcium-Binding Proteins/chemistry/genetics/metabolism/toxicity, Catalytic Domain/genetics, Cattle, Cell Line, Cell Membrane/metabolism, Clostridium perfringens/pathogenicity, Creatine Kinase/blood, Crystallization, Endothelial Cells/drug effects/pathology, Host-Pathogen Interactions, Humans, Mice, Mice, Inbred Strains, Mutant Proteins/chemistry/genetics/metabolism/toxicity, Phospholipids/metabolism, Protein Binding, Protein Conformation, Substrate Specificity/genetics, Type C Phospholipases/*chemistry/genetics/metabolism/toxicity	Pathogenicity	Metabolism	*
Lytic enzyme discovery through multigenomic sequence analysis in Clostridium perfringens.	Schmitz JE, Ossiprandi MC, Rumah KR, Fischetti VA	Appl Microbiol Biotechnol	10.1007/s00253-010-2982-8	2010	Amino Acid Sequence, Bacteriophages/enzymology/genetics, Cloning, Molecular, Clostridium perfringens/enzymology/genetics/virology, Cluster Analysis, Computational Biology/methods, Endopeptidases/genetics/isolation & purification/metabolism, Enzyme Stability, Gene Expression, *Genome, Bacterial, Hydrogen-Ion Concentration, Molecular Sequence Data, Phylogeny, Recombinant Proteins/chemistry/genetics/isolation & purification/metabolism, Sequence Analysis, Sequence Homology, Amino Acid, Temperature	Enzymology	Phylogeny	*
Structural analysis of CPF_2247, a novel alpha-amylase from Clostridium perfringens.	Ficko-Blean E, Stuart CP, Boraston AB	Proteins	10.1002/prot.23116	2011	Amino Acid Sequence, Bacterial Proteins/chemistry/genetics/metabolism, Clostridium perfringens/enzymology, Crystallography, X-Ray, Molecular Sequence Data, Protein Conformation, Protein Structure, Secondary, Protein Structure, Tertiary, Sequence Homology, Amino Acid, alpha-Amylases/chemistry/genetics/metabolism	Metabolism	Genetics	*
Use of gamma-irradiation to reduce Clostridium perfringens on ready-to-eat bovine tripe.	Parry-Hanson A, Hall A, Minnaar A, Buys EM	Meat Sci	10.1016/j.meatsci.2007.06.010	2007				*
Comparative transcription analysis and toxin production of two fluoroquinolone-resistant mutants of Clostridium perfringens.	Park S, Park M, Rafii F	BMC Microbiol	10.1186/1471-2180-13-50	2013	Anti-Bacterial Agents/pharmacology, Bacterial Toxins/metabolism, Clostridium perfringens/drug effects/genetics/metabolism, Drug Resistance, Bacterial, Fluoroquinolones/pharmacology, Microarray Analysis, Real-Time Polymerase Chain Reaction, Selection, Genetic, *Transcriptome	Pathogenicity	Metabolism	*
A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.	Nagahama M, Oda M, Kobayashi K, Ochi S, Takagishi T, Shibutani M, Sakurai J	Microbiol Immunol	10.1111/1348-0421.12036	2013	Animals, Antibodies, Bacterial/blood, Antibodies, Neutralizing/blood, Antitoxins/blood, Bacterial Toxins/genetics/immunology, Bacterial Vaccines/administration & dosage/genetics/immunology, Calcium-Binding Proteins/genetics/immunology, Clostridium Infections/immunology/prevention & control, Clostridium perfringens/immunology, Disease Models, Animal, Female, Mice, Mice, Inbred BALB C, Neutralization Tests, Recombinant Proteins/genetics/immunology, Survival Analysis, Type C Phospholipases/genetics/immunology, Vaccines, Synthetic/administration & dosage/genetics/immunology	Pathogenicity		*
Effect of fluoroquinolone resistance selection on the fitness of three strains of Clostridium perfringens.	Park M, Sutherland JB, Kim JN, Rafii F	Microb Drug Resist	10.1089/mdr.2013.0056	2013	Anti-Bacterial Agents/pharmacology, Ciprofloxacin/pharmacology, Clostridium perfringens/drug effects/genetics/growth & development, Drug Resistance, Bacterial/genetics, Fluoroquinolones/pharmacology, Gatifloxacin, Genetic Fitness/drug effects, Microbial Sensitivity Tests, Microbial Viability/drug effects, Mutation, Norfloxacin/pharmacology	Pathogenicity		*
Growth-Inhibiting and morphostructural effects of constituents identified in Asarum heterotropoides root on human intestinal bacteria.	Perumalsamy H, Jung MY, Hong SM, Ahn YJ	BMC Complement Altern Med	10.1186/1472-6882-13-245	2013	Asarum/chemistry, Bacteria/drug effects, Cell Shape/drug effects, Gastrointestinal Tract/drug effects/microbiology, Humans, Microbial Sensitivity Tests, Microbiota/drug effects, Plant Extracts/chemistry/*pharmacology, Plant Roots/chemistry	Pathogenicity		*
Inhibition of Clostridium perfringens growth by potassium lactate during an extended cooling of cooked uncured ground turkey breasts.	Kennedy KM, Milkowski AL, Glass KA	J Food Prot	10.4315/0362-028X.JFP-13-106	2013	Animals, Clostridium perfringens/drug effects/growth & development/physiology, Cold Temperature, Colony Count, Microbial, Dose-Response Relationship, Drug, Food Contamination/analysis/prevention & control, Food Handling/methods, Food Microbiology, Food Preservation/methods, Food Preservatives/pharmacology, Humans, Poultry Products/*microbiology, Sodium Lactate/pharmacology, Turkeys, United States	Pathogenicity	Biotechnology	*
Comparative analysis of extractable proteins from Clostridium perfringens type A and type C strains showing varying degree of virulence.	Dwivedi P, Alam SI, Kumar O, Kumar RB	Anaerobe	10.1016/j.anaerobe.2015.07.006	2015	Animals, Bacterial Proteins/analysis/isolation & purification, Clostridium Infections/microbiology, Clostridium perfringens/chemistry/pathogenicity, Disease Models, Animal, Electrophoresis, Gel, Two-Dimensional, Mass Spectrometry, Mice, Proteome/analysis/isolation & purification, Survival Analysis, Virulence, Virulence Factors/analysis/isolation & purification	Enzymology	Phylogeny	*
Changes in microbial community during biohydrogen production using gamma irradiated sludge as inoculum.	Yin Y, Wang J	Bioresour Technol	10.1016/j.biortech.2015.10.027	2015	Biofuels, Gamma Rays, Hydrogen/metabolism, Microbial Consortia/genetics/radiation effects, Sewage/*microbiology	Biotechnology	Metabolism	*
Identification of a Bacteria-Specific Binding Protein from the Sequenced Bacterial Genome.	Kong M, Ryu S	J Microbiol Biotechnol	10.4014/jmb.1510.10056	2016	Amino Acid Sequence, Bacterial Proteins/chemistry/genetics/metabolism, Carrier Proteins/chemistry/genetics/metabolism, Clostridium perfringens/chemistry/genetics/metabolism, Genome, Bacterial, Molecular Sequence Data, Protein Binding, Protein Structure, Tertiary, Sequence Alignment/*methods	Genetics	Metabolism	*
Cloning, characterization, and production of three alpha-L-fucosidases from Clostridium perfringens ATCC 13124.	Fan S, Zhang H, Chen X, Lu L, Xu L, Xiao M	J Basic Microbiol	10.1002/jobm.201500582	2015	Animals, Cloning, Molecular, Clostridium perfringens/enzymology/genetics, Enzyme Activation, Escherichia coli/genetics, Fucose/metabolism, Gastric Mucins/metabolism, Glutamic Acid/metabolism, Mutagenesis, Site-Directed, Polysaccharides/metabolism, Substrate Specificity, Swine, alpha-L-Fucosidase/biosynthesis/genetics	Enzymology	Metabolism	*
Screening of Bacteriocin-producing Enterococcus faecalis Strains for Antagonistic Activities against Clostridium perfringens.	Han SK, Shin MS, Park HE, Kim SY, Lee WK	Korean J Food Sci Anim Resour	10.5851/kosfa.2014.34.5.614	2014				*
The Details of Glycolipid Glycan Hydrolysis by the Structural Analysis of a Family 123 Glycoside Hydrolase from Clostridium perfringens.	Noach I, Pluvinage B, Laurie C, Abe KT, Alteen MG, Vocadlo DJ, Boraston AB	J Mol Biol	10.1016/j.jmb.2016.03.020	2016	Catalysis, Catalytic Domain/physiology, Clostridium perfringens/metabolism, Galactose/metabolism, Glycolipids/metabolism, Glycoside Hydrolases/*metabolism, Hydrolysis, beta-N-Acetyl-Galactosaminidase/metabolism	Metabolism		*
Ex vivo pharmacokinetic/pharmacodynamic relationship of valnemulin against Clostridium perfringens in plasma, the small intestinal and caecal contents of rabbits.	Zhou YF, Yu Y, Sun J, Tao MT, Zhou WJ, Li X, Liao XP, Liu YH	Anaerobe	10.1016/j.anaerobe.2016.04.005	2016	Administration, Oral, Animals, Anti-Bacterial Agents/blood/pharmacokinetics/pharmacology, Cecum/drug effects/microbiology, Clostridium Infections/blood/drug therapy/microbiology, Clostridium perfringens/*drug effects/growth & development, Diterpenes/blood/pharmacokinetics/pharmacology, Drug Administration Schedule, Female, Half-Life, Injections, Intravenous, Intestine, Small/drug effects/microbiology, Male, Microbial Sensitivity Tests, Rabbits	Pathogenicity	Enzymology	*
Putative function of hypothetical proteins expressed by Clostridium perfringens type A strains and their protective efficacy in mouse model.	Alam SI, Dwivedi P	Infect Genet Evol	10.1016/j.meegid.2016.06.040	2016	Animals, Bacterial Proteins/genetics/immunology/metabolism, Cloning, Molecular, Clostridium perfringens/genetics/*pathogenicity, Disease Models, Animal, Escherichia coli/genetics, Female, Gas Gangrene/immunology, Mice, Inbred BALB C, Phylogeny, Recombinant Proteins/genetics/immunology/metabolism	Metabolism	Enzymology	*
Efficient and Regioselective Synthesis of beta-GalNAc/GlcNAc-Lactose by a Bifunctional Transglycosylating beta-N-Acetylhexosaminidase from Bifidobacterium bifidum.	Chen X, Xu L, Jin L, Sun B, Gu G, Lu L, Xiao M	Appl Environ Microbiol	10.1128/AEM.01325-16	2016	Acetylgalactosamine/metabolism, Acetylglucosamine/metabolism, Bacteroides fragilis/enzymology/genetics, Bifidobacterium bifidum/enzymology/genetics, Cloning, Molecular, Clostridium perfringens/enzymology/genetics, Enzyme Stability, Escherichia coli/genetics/metabolism, Gene Expression, Hydrogen-Ion Concentration, Kinetics, Lactose/metabolism, Molecular Docking Simulation, Recombinant Proteins/chemistry/genetics/isolation & purification/metabolism, Temperature, beta-N-Acetylhexosaminidases/chemistry/genetics/isolation & purification/*metabolism	Enzymology	Metabolism	*
Effect of Trehalose and Trehalose Transport on the Tolerance of Clostridium perfringens to Environmental Stress in a Wild Type Strain and Its Fluoroquinolone-Resistant Mutant.	Park M, Mitchell WJ, Rafii F	Int J Microbiol	10.1155/2016/4829716	2016		Stress		*
Exposure to beta-lactams results in the alteration of penicillin-binding proteins in Clostridium perfringens.	Park M, Rafii F	Anaerobe	10.1016/j.anaerobe.2017.02.004	2017	Animals, Anti-Bacterial Agents/pharmacology, Cattle, Chickens, Clostridium Infections/microbiology/veterinary, Clostridium perfringens/drug effects/enzymology/isolation & purification, DNA Mutational Analysis, Mutation, Missense, Penicillin-Binding Proteins/genetics, Selection, Genetic, beta-Lactam Resistance, beta-Lactams/*pharmacology	Enzymology	Phylogeny	*
Effect of continuous sub-culturing on infectivity of Clostridium perfringens ATCC13124 in mouse gas gangrene model.	Kumar RB, Alam SI	Folia Microbiol (Praha)	10.1007/s12223-017-0503-1	2017	Animals, Bacterial Proteins/genetics/metabolism, Clostridium perfringens/genetics/growth & development/physiology, Disease Models, Animal, Gas Gangrene/microbiology, Host-Pathogen Interactions, Humans, Mice, Mice, Inbred BALB C	Pathogenicity	Metabolism	*
Structural characterization of wall and lipidated polysaccharides from Clostridium perfringens ATCC 13124.	Vinogradov E, Aubry A, Logan SM	Carbohydr Res	10.1016/j.carres.2017.06.003	2017	Animals, Cell Wall/chemistry, Clostridium perfringens/chemistry/cytology, Lipid Metabolism, Lipopolysaccharides/chemistry, Polysaccharides/chemistry/immunology/metabolism, Rabbits, Teichoic Acids/chemistry	Metabolism		*
Enzymatic Synthesis of 6'-Sialyllactose, a Dominant Sialylated Human Milk Oligosaccharide, by a Novel exo-alpha-Sialidase from Bacteroides fragilis NCTC9343.	Guo L, Chen X, Xu L, Xiao M, Lu L	Appl Environ Microbiol	10.1128/AEM.00071-18	2018	Bacteroides fragilis/enzymology/genetics, Bifidobacterium bifidum/enzymology/genetics, Cloning, Molecular, Clostridium perfringens/enzymology/genetics, Escherichia coli/genetics, Gene Expression Regulation, Bacterial, Humans, Hydrogen-Ion Concentration, Infant Formula, Lactose/analogs & derivatives/biosynthesis/metabolism, Milk, Human/chemistry, Models, Molecular, Molecular Weight, Neuraminidase/genetics/isolation & purification/metabolism, Oligosaccharides/*metabolism, Protein Domains, Recombinant Proteins, Sequence Alignment, Sequence Analysis, Sialic Acids/metabolism, Substrate Specificity, Temperature, Time Factors	Enzymology	Metabolism	*
Inhibition of Clostridium perfringens using Bacteriophages and Bacteriocin Producing Strains.	Heo S, Kim MG, Kwon M, Lee HS, Kim GB	Korean J Food Sci Anim Resour	10.5851/kosfa.2018.38.1.88	2018				*
Evaluation of Lactobacillus plantarum encapsulated with Eleutherine americana oligosaccharide extract as food additive in yoghurt.	Phoem AN, Mayiding A, Saedeh F, Permpoonpattana P	Braz J Microbiol	10.1007/s42770-018-0017-2	2018	Food Additives/chemistry, Food Microbiology/methods, Iridaceae/chemistry, Lactobacillus plantarum/chemistry/growth & development, Microbial Viability, Oligosaccharides/chemistry, Plant Extracts/chemistry, Probiotics/chemistry, Yogurt/analysis/microbiology	Biotechnology		*
[A study on clinical application of a novel reagent detecting toxigenic strains of Clostridium difficile].	Wang SM, Wang ZY	Zhonghua Yi Xue Za Zhi	10.3760/cma.j.issn.0376-2491.2018.48.013	2018	Bacterial Toxins, Clostridioides difficile, Clostridium Infections, Feces, Humans, Polymerase Chain Reaction	Pathogenicity		*
Galleria mellonella Infection Model Identifies Both High and Low Lethality of Clostridium perfringens Toxigenic Strains and Their Response to Antimicrobials.	Kay S, Edwards J, Brown J, Dixon R	Front Microbiol	10.3389/fmicb.2019.01281	2019				*
Capsular Polysaccharide Is a Receptor of a Clostridium perfringens Bacteriophage CPS1.	Ha E, Chun J, Kim M, Ryu S	Viruses	10.3390/v11111002	2019	Bacterial Capsules/chemistry/genetics, Bacterial Proteins/genetics, Bacteriophages/genetics/isolation & purification, Carbohydrate Epimerases/genetics, Clostridium perfringens/genetics/virology, Genes, Bacterial, Genome, Viral, Phylogeny, Podoviridae/classification/genetics/isolation & purification/ultrastructure, Polysaccharides, Bacterial/genetics, Receptors, Virus/*genetics, UDPglucose 4-Epimerase/genetics	Phylogeny	Enzymology	*
beta-Lactam resistance development affects binding of penicillin-binding proteins (PBPs) of Clostridium perfringens to the fluorescent penicillin, BOCILLIN FL.	Park M, Sutherland JB, Rafii F	Anaerobe	10.1016/j.anaerobe.2020.102179	2020	Anti-Bacterial Agents/pharmacology, Bacterial Proteins/genetics, Clostridium Infections/diagnosis/microbiology, Clostridium perfringens/drug effects/genetics, Gene Expression Regulation, Bacterial, Humans, Penicillin-Binding Proteins/genetics, Penicillins/pharmacology, Real-Time Polymerase Chain Reaction, *beta-Lactam Resistance	Pathogenicity		*
Antibiotic resistance, genome analysis and further safe traits of Clostridium perfringens ICVB082; a strain capable of producing an inhibitory compound directed only against a closely related pathogenic strain.	Vieco-Saiz N, Belguesmia Y, Vachee A, Le Marechal C, Salvat G, Drider D	Anaerobe	10.1016/j.anaerobe.2020.102177	2020	Animals, Anti-Bacterial Agents/pharmacology, Antibiosis, Bacterial Toxins/genetics, Clostridium Infections/veterinary, Clostridium perfringens/drug effects/genetics/pathogenicity, Drug Resistance, Bacterial, Drug Resistance, Multiple, Bacterial, Genome, Bacterial, Hemolysis, Phylogeny, Poultry Diseases/microbiology, RNA, Ribosomal, 16S, Virulence, Virulence Factors	Phylogeny	Pathogenicity	*
Biodiversity and Phylogenetic Relationships of Novel Bacteriocinogenic Strains Isolated from Animal's Droppings at the Zoological Garden of Lille, France.	Eveno M, Salouhi A, Belguesmia Y, Bazinet L, Gancel F, Fliss I, Drider D	Probiotics Antimicrob Proteins	10.1007/s12602-020-09657-4	2021	Animals, Animals, Zoo/microbiology, Bacteria/classification/genetics/isolation & purification/metabolism, Bacteriocins/biosynthesis/genetics, Biodiversity, Feces/microbiology, France, Phylogeny	Phylogeny	Enzymology	*
Dual Inhibition of Salmonella enterica and Clostridium perfringens by New Probiotic Candidates Isolated from Chicken Intestinal Mucosa.	Lone A, Mottawea W, Ait Chait Y, Hammami R	Microorganisms	10.3390/microorganisms9010166	2021		Phylogeny		*
In-laboratory quality control of nutrients for automatic bacteriology analyzer YUNON(R)Labstar 50.	Boronina LG, Samatova EV, Kukushkina MP, Panova SA, Ustyugova SS	Klin Lab Diagn	10.51620/0869-2084-2021-66-2-110-114	2021	Anti-Bacterial Agents, Bacterial Infections, Bacteriology, Child, Humans, Laboratories, Microbial Sensitivity Tests, Nutrients, Quality Control	Pathogenicity		*

References

#428	Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 756

#20215

Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )

#20218

Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 )

#42056 ; Curators of the CIP;
#44424 Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 1795

#66792

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#67770 Japan Collection of Microorganism (JCM) ; Curators of the JCM;

#68367

Automatically annotated from API 20A .

#68380

Automatically annotated from API rID32A .

* These data were automatically processed and therefore are not curated

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Search for species Clostridium perfringens in external resources:
SILVA
BRENDA
PANGAEA
StrainInfo
GBIF